We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What is CIDP?

Malcolm Tatum
Updated: Mar 03, 2024

Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), is a disorder that impacts both the central and peripheral nervous systems. While people of any age or gender can develop CIDP, the disorder usually strikes men who are under the age of 30. In some cases, CIDP may disappear as quickly as it developed and never trouble the individual again. In other cases, the disorder seems to return periodically throughout the life of the person. There is also the potential for lingering side effects from the disorder.

The cause for CIDP appears to be a malfunction of the body’s immune system. Because the immune system fights anything perceived as a foreign substance to be a threat to the body, the system begins to produce antibodies in order to isolate and eventually eradicate the intruder. CIDP occurs when the immune system begins to identify the myelin sheath that surrounds the nerve fibers in the peripheral nervous system as a foreign substance. As the immune system seeks to destroy the sheaths, the nerve fibers are unable to function properly and a series of CIDP symptoms begin to appear.

CIDP symptoms are focused on the development and progression of problems in the legs and arms. As the sheaths around the peripheral nerves are weakened, the sensory function and the ability to control movement is impaired. An individual with CIDP will often begin to experience a sense of weakness in the arms and legs that seems to get worse over time, even with regular exercise. Numbness or a tingling sensation in the fingers and toes may also begin to appear. Overwhelming fatigue is also a common symptom.

Fortunately, there are effective ways to treat the symptoms of CIDP. When identified in the early stages, CIDP treatment will usually employ a combination of regular exercise and the use of drugs that will help to suppress the production of antibodies that attack the myelin sheath. Intravenous immunoglobulin therapy may be used to help alleviate some of the symptoms, such as the numbness or loss of sensation in the extremities. In some cases, CIDP treatment may include the use of corticosteriods along with the application of drugs to suppress the function of the immune system. During the treatment phase, it is important to monitor progress regularly and adjust the treatment process as needed.

It is possible for CIDP to go into recession without the use of drugs or intravenous therapies of any type. This is not usually the case, however.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Malcolm Tatum
By Malcolm Tatum
Malcolm Tatum, a former teleconferencing industry professional, followed his passion for trivia, research, and writing to become a full-time freelance writer. He has contributed articles to a variety of print and online publications, including The Health Board, and his work has also been featured in poetry collections, devotional anthologies, and newspapers. When not writing, Malcolm enjoys collecting vinyl records, following minor league baseball, and cycling.
Discussion Comments
By anon144841 — On Jan 21, 2011

cidpusa has very good information.

By anon55739 — On Dec 09, 2009

Thanks for the excellent information and you have opened my eyes.

By anon24688 — On Jan 16, 2009

Does an MRI show changes in the myelin sheath with CIDP in the early stages?

Malcolm Tatum
Malcolm Tatum
Malcolm Tatum, a former teleconferencing industry professional, followed his passion for trivia, research, and writing...
Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.